Explanipedia

Reply to “Letter to the Editor: Comments on gender differences in acute heart failure study” Open

P.B. Jayagopal, C.N. Manjunath, Jabir Abdullakutty, Sridhar Lakshmana Sastry, Veena Nanjappa , et al. · 2025

Comparison of dual therapies for hypertension treatment in India: a randomized clinical trial Open

Dorairaj Prabhakaran, Ambuj Roy, Ambalam M. Chandrasekaran, Dimple Kondal, Somnath Mukherjee , et al. · 2025

Real-World Evaluation of the Dosage Patterns and Safety of Angiotensin Receptor-Neprilysin Inhibitor Therapy in Indian Patients With Heart Failure With Reduced Ejection Fraction: The ADD-ARNI Study Protocol Open

Sanjay Mittal, Ashwani Mehta, Kamal Sharma, P.B. Jayagopal, Arindam Pande , et al. · 2025

Correction to: Association Between Type 2 Diabetes Mellitus and Heart Failure: A Retrospective Study from a Tertiary Care Diabetes Centre in India Open

Rajendra Pradeepa, Thyparambil Aravindakshan Pramodkumar, Ranjit Mohan Anjana, Saravanan Jebarani, Abdul Subhan Naziyagulnaaz , et al. · 2025

Association Between Type 2 Diabetes Mellitus and Heart Failure: A Retrospective Study from a Tertiary Care Diabetes Centre in India Open

Rajendra Pradeepa, Thyparambil Aravindakshan Pramodkumar, Ranjit Mohan Anjana, Saravanan Jebarani, Abdul Subhan Naziyagulnaaz , et al. · 2025

Identifying Drug Prescription in Newly Diagnosed Hypertension Patients in India Open

Thomas Alexander, Jagdish Hiremath, Jitendra P. S. Swahney, Subhash Chandra, Peeyush Jain , et al. · 2025

This study evaluated initial antihypertensive drug prescription patterns in Indian healthcare settings. An observational, cross‐sectional, prospective prescription registry analyzed prescriptions for 4723 newly diagnosed hypertension patie…

Studying the trend of HbA1C changes with NYHA class with SGLT2i in HFrEF T2DM Indian patients - A post-hoc analysis of REMIT-HF Open

Shantanu Sengupta, Rahee Borulkar, P.B. Jayagopal, J.P.S. Sawhney, Ashwani Mehta , et al. · 2024

Open-label, Randomized, Multi-Centre study to evaluate safety and efficacy of Remogliflozin in patients with Type 2 diabetes mellitus with acute decompensated heart failure (HF with reduced ejection fraction, HFrEF). (Remo Safe-AHF Study) Open

Sumit Bhushan, Harshwardhan Mardikar, Niteen Deshpande, P.B. Jayagopal, Abhishek Mane , et al. · 2023

A real-world analysis of outcomes and healthcare costs of patients on perindopril/indapamide/amlodipine single-pill vs. multiple-pill combination in Italy Open

J. R. Snyman, Luiz Aparecido Bortolotto, Luca Degli Esposti, P.B. Jayagopal, А. О. Конради , et al. · 2023

Objectives: This analysis compared adherence, cardiovascular (CV) events and all-cause mortality incidence, and healthcare costs among hypertensive patients treated with perindopril (PER)/indapamide (IND)/amlodipine (AML) in single-pill co…

Indian Real-world Evidence of Rivaroxaban Use in Coronary Artery Disease – A Prospective Observational Cohort Study (IN-RECORD): Study Design and Baseline Characteristics Open

P.B. Jayagopal, Bagirath Raghuraman, Anup Khetan, Vilas Magarkar, Rajendra Kumar Premchand , et al. · 2023

Background: Antiplatelet therapy (APT) is the cornerstone for cardiovascular (CV) prevention in patients with coronary artery disease (CAD). However, there is potential for greater effectiveness in vascular prevention for patients with sta…

COVID-19 infected ST-Elevation myocardial infarction in India (COSTA INDIA) Open

Jabir Abdullakutty, Geevar Zachariah, P.P. Mohanan, Mohit Gupta, Sivasubramanian Ramakrishnan , et al. · 2023

410 COVID-19 positive STEMI cases were compared with 799 COVID-19 negative STEMI cases. The composite of death/reinfarction/stroke/heart failure was significantly higher among the COVID-19 positive STEMI patients compared with COVID-19 neg…

Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies in ST-segment Elevation Myocardial Infarction Patients and its Impact on Thrombus in the Coronaries Open

P.B. Jayagopal, R Omnath · 2023

Objective: Higher thrombus load and poorer outcomes have been reported in coronavirus disease 2019 (COVID-19) patients with ST-segment elevation myocardial infarction (STEMI). The presence of antibodies to the COVID-19 infection has been l…

Adherence to Triple Single-Pill Combination of Perindopril/Indapamide/Amlodipine: Findings from Real-World Analysis in Italy Open

Claudio Borghi, P.B. Jayagopal, А. О. Конради, Luiz Aparecido Bortolotto, Luca Degli Esposti , et al. · 2023

A Retrospective, Observational, EMR-Based Real-World Evidence Study to Assess the Incidence of Pedal Edema in Essential Hypertensive Patients on Amlodipine or Cilnidipine Open

Jamshed Dalal, J.P.S. Sawhney, P.B. Jayagopal, Prakash Kumar Hazra, Mohammed Yunus Khan , et al. · 2022

Introduction. Calcium channel blockers have pedal edema as one of the confining factors of treatment. A real-world study may help evident reality of the situation in regular Indian clinical practice. The aim of the study is to assess effec…

Polypill Eligibility for Patients with Heart Failure With Reduced Ejection Fraction in South India: A Secondary Analysis of a Prospective, Interrupted Time Series Study Open

Aishwarya Vijay, P.P. Mohanan, Dimple Kondal, Abigail S. Baldridge, Divin Davies , et al. · 2021

Presentation, Management, and In-Hospital Outcomes of Patients with Acute Heart Failure in South India by Sex: A Secondary Analysis of a Prospective, Interrupted Time Series Study Open

Anubha Agarwal, P.P. Mohanan, Dimple Kondal, Aashima Chopra, Abigail S. Baldridge , et al. · 2021

We observed sex-specific differences in presentation and procedural management of patients with HF but no differences in the effect of the quality improvement intervention on discharge GDMT rates. Both male and female patients with HFrEF r…

Acute decompensated heart failure (ADHF) during COVID-19 pandemic-insights from South India Open

P.B. Jayagopal, Jabir Abdullakutty, L Sridhar, Veena Nanjappa, Johny Joseph , et al. · 2021

This study from the registry shows that the incidence of ADHF admissions during COVID-19 lockdown significantly reduced compared to the previous year. Demographic patterns remained similar but patients presenting with de-novo HF increased;…

Changing pattern of admissions for acute myocardial infarction in India during the COVID-19 pandemic Open

Geevar Zachariah, Sivasubramanian Ramakrishnan, Mrinal Kanti Das, Jabir Abdullakutty, P.B. Jayagopal , et al. · 2021

Effect of a quality improvement intervention for acute heart failure in South India: An interrupted time series study Open

Anubha Agarwal, P.P. Mohanan, Dimple Kondal, Abigail S. Baldridge, Divin Davies , et al. · 2020

One-year clinical outcome of patients with nonvalvular atrial fibrillation: Insights from KERALA-AF registry Open

C.G. Bahuleyan, Narayanan Namboodiri, A. Jabir, Gregory Y.H. Lip, George Koshy A , et al. · 2020

Impact of the 2017 ACC/AHA guidelines on the prevalence of hypertension among Indian adults: Results from a cross-sectional survey Open

Kartik Gupta, Sivasubramanian Ramakrishnan, Geevar Zachariah, J. Shivkumar Rao, Padhinhare P. Mohanan , et al. · 2020

Pattern of acute MI admissions in India during COVID-19 era: A Cardiological Society of India study - Rationale and design Open

Sivasubramanian Ramakrishnan, Jabir Abdullakutty, P.B. Jayagopal, P.P. Mohanan, K. Venugopal , et al. · 2020

Cardiological society of India document on safety measure during echo evaluation of cardiovascular disease in the time of COVID-19 Open

Rakesh Gupta, Mrinal Kanti Das, P.P. Mohanan, Pradip Kumar Deb, Samiksha Parashar , et al. · 2020

Cardiological society of India position statement on COVID-19 and heart failure Open

S Harikrishnan, P.P. Mohanan, Vijay Chopra, Roy Ambuj, Sanjay Ganapathi , et al. · 2020

Cardiological Society of India: Document on acute MI care during COVID-19 Open

P.G. Kerkar, Nitish Naik, Thomas H. Alexander, Vinay K. Bahl, Rajarshi Chakraborty , et al. · 2020

Consensus statement for the management of dyslipidemia and hypertension in the Indian population with diabetes Open

P.B. Jayagopal, M. Srinivas Rao, R. Vijaykumar, Soumitra Kumar, Girish Parthan · 2019

The mortality rate from cardiovascular disease (CVD) in India is higher than the global figures (272 per 100,000 persons vs. 235 per 100,000 persons, respectively). Smoking, obesity, hypertension, diabetes and dyslipidemia are the known ri…

Cardiological Society of India: Position statement for the management of ST elevation myocardial infarction in India Open

Santanu Guha, Rishi Sethi, Saumitra Ray, Vinay K. Bahl, Saseendar Shanmugasundaram , et al. · 2017

P.B. Jayagopal YOU? Author Swipe